NL175178C - Werkwijze om 2,4-diamino-5-benzylpyrimidinederivaten en farmaceutische preparaten die deze stoffen bevatten te bereiden. - Google Patents

Werkwijze om 2,4-diamino-5-benzylpyrimidinederivaten en farmaceutische preparaten die deze stoffen bevatten te bereiden.

Info

Publication number
NL175178C
NL175178C NLAANVRAGE7114494,A NL7114494A NL175178C NL 175178 C NL175178 C NL 175178C NL 7114494 A NL7114494 A NL 7114494A NL 175178 C NL175178 C NL 175178C
Authority
NL
Netherlands
Prior art keywords
diamino
substances
preparing
pharmaceutical preparations
preparations containing
Prior art date
Application number
NLAANVRAGE7114494,A
Other languages
English (en)
Dutch (nl)
Other versions
NL7114494A (es
NL175178B (nl
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NL7114494A publication Critical patent/NL7114494A/xx
Publication of NL175178B publication Critical patent/NL175178B/xx
Application granted granted Critical
Publication of NL175178C publication Critical patent/NL175178C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NLAANVRAGE7114494,A 1970-10-22 1971-10-21 Werkwijze om 2,4-diamino-5-benzylpyrimidinederivaten en farmaceutische preparaten die deze stoffen bevatten te bereiden. NL175178C (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB963871*[A GB1375162A (es) 1970-10-22 1970-10-22
GB963871 1971-04-16
GB4749171 1971-10-12

Publications (3)

Publication Number Publication Date
NL7114494A NL7114494A (es) 1972-04-25
NL175178B NL175178B (nl) 1984-05-01
NL175178C true NL175178C (nl) 1984-10-01

Family

ID=27255400

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7114494,A NL175178C (nl) 1970-10-22 1971-10-21 Werkwijze om 2,4-diamino-5-benzylpyrimidinederivaten en farmaceutische preparaten die deze stoffen bevatten te bereiden.

Country Status (20)

Country Link
JP (2) JPS5536662B1 (es)
AR (3) AR192588A1 (es)
AT (1) AT319948B (es)
BE (1) BE774281A (es)
BG (4) BG20797A3 (es)
CA (1) CA967158A (es)
CH (3) CH568301A5 (es)
DD (1) DD100877A5 (es)
DK (1) DK132174C (es)
ES (1) ES396219A1 (es)
FI (1) FI56175C (es)
FR (1) FR2111769B1 (es)
GB (1) GB1375162A (es)
IE (1) IE37452B1 (es)
IL (2) IL45422A (es)
LU (1) LU64129A1 (es)
MC (1) MC894A1 (es)
NL (1) NL175178C (es)
SE (2) SE384505B (es)
ZM (1) ZM14971A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
FR2397407A2 (fr) * 1977-07-11 1979-02-09 Dick Pierre Derives de 2,4-diamino pyrimidines et leur mise en solution en association avec des sulfamides
IL57375A0 (en) * 1978-05-24 1979-09-30 Wellcome Found Benzylpyrimidines, their preparation and pharmaceutical compositions containing them
JPS61156909A (ja) * 1984-12-27 1986-07-16 Matsushita Electric Ind Co Ltd カレント・ミラ−回路
JPS62145907A (ja) * 1985-12-20 1987-06-30 Hitachi Ltd トランジスタ回路
TWI392678B (zh) 2004-03-26 2013-04-11 Dainippon Sumitomo Pharma Co 9-取代-8-氧基腺嘌呤化合物
JP2009542645A (ja) 2006-07-05 2009-12-03 アストラゼネカ・アクチエボラーグ Tlr7のモジュレーターとして作用する8−オキソアデニン誘導体
TW200831105A (en) 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
US8067413B2 (en) 2007-03-19 2011-11-29 Astrazeneca Ab 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators
WO2008114006A1 (en) 2007-03-19 2008-09-25 Astrazeneca Ab 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
WO2008114819A1 (ja) 2007-03-20 2008-09-25 Dainippon Sumitomo Pharma Co., Ltd. 新規アデニン化合物
PE20091236A1 (es) * 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
PE20091156A1 (es) 2007-12-17 2009-09-03 Astrazeneca Ab Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
SG175796A1 (en) 2009-05-21 2011-12-29 Astrazeneca Ab Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
GB0908772D0 (en) 2009-05-21 2009-07-01 Astrazeneca Ab New salts 756
JP5978225B2 (ja) 2010-12-16 2016-08-24 大日本住友製薬株式会社 治療に有用なイミダゾ[4,5−c]キノリン−1−イル誘導体
EP2651943B1 (en) 2010-12-17 2017-03-22 Sumitomo Dainippon Pharma Co., Ltd. Purine derivatives
AU2013261267B2 (en) 2012-05-18 2017-06-29 Sumitomo Pharma Co., Ltd. Carboxylic acid compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE710100A (es) * 1967-02-02 1968-07-30
JPS511716A (ja) * 1974-06-25 1976-01-08 Toray Industries Horiesuterumaruchifuiramentono seiho

Also Published As

Publication number Publication date
DK132174B (da) 1975-11-03
IL37984A0 (en) 1971-12-29
FR2111769A1 (es) 1972-06-09
FI56175C (fi) 1979-12-10
GB1375162A (es) 1974-11-27
IL37984A (en) 1976-03-31
AR192802A1 (es) 1973-03-14
AT319948B (de) 1975-01-10
AR192803A1 (es) 1973-03-14
FR2111769B1 (es) 1974-10-18
BG20797A3 (es) 1975-12-20
BG20364A3 (es) 1975-11-05
ZM14971A1 (en) 1972-07-21
FI56175B (fi) 1979-08-31
BE774281A (fr) 1972-04-21
JPS53135991A (en) 1978-11-28
IE37452B1 (en) 1977-08-03
IE37452L (en) 1972-04-22
CH582681A5 (es) 1976-12-15
SE384505B (sv) 1976-05-10
ES396219A1 (es) 1975-09-16
JPS5536662B1 (es) 1980-09-22
IL45422A (en) 1976-03-31
LU64129A1 (es) 1972-06-28
BG20365A3 (es) 1975-11-05
AR192588A1 (es) 1973-02-28
CH568301A5 (es) 1975-10-31
MC894A1 (fr) 1972-06-22
CA967158A (en) 1975-05-06
NL7114494A (es) 1972-04-25
BG21406A3 (es) 1976-05-20
SE409705B (sv) 1979-09-03
DD100877A5 (es) 1973-10-12
CH568302A5 (es) 1975-10-31
DK132174C (da) 1976-03-29
NL175178B (nl) 1984-05-01

Similar Documents

Publication Publication Date Title
NL7411047A (nl) Werkwijze ter bereiding van nieuwe pyrimidinen en van farmaceutische preparaten, die dergelij- ke pyrimidinen bevatten.
NL174943C (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van een 8-azapurin-6-onderivaat.
NL154500B (nl) Werkwijze ter bereiding van 2-cyclohexeen-1-on-derivaten en van herbicide preparaten, die deze bevatten.
NL7414186A (nl) Werkwijze ter bereiding van 1-ftalazonderivaten alsmede van farmaceutische preparaten die deze derivaten als actieve componenten omvatten.
NL175178C (nl) Werkwijze om 2,4-diamino-5-benzylpyrimidinederivaten en farmaceutische preparaten die deze stoffen bevatten te bereiden.
NL174547C (nl) Werkwijze ter bereiding van benzoylpropionzuurderivaten, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
IL37547A (en) Isoindoline derivatives,processes for their preparation and pharmaceutical preparations containing the same
NL7501032A (nl) Werkwijze ter bereiding van anti-tuberkelmid- delen, alsmede farmaceutische preparaten die deze middelen bevatten.
NL171444C (nl) Werkwijze voor de bereiding van 1,2,3,4-tetrahydro-4-fenylisochinolinederivaten, alsmede werkwijze voor de bereiding van farmaceutische preparaten met antidepressieve eigenschappen, die deze derivaten bevatten.
NL168210B (nl) Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van cyclische carbon- zuurderivaten.
NL172240C (nl) Werkwijze om pteridinederivaten te bereiden en farmaceutische preparaten, welke deze verbindingen bevatten.
NL7409752A (nl) Werkwijze ter bereiding van 1,4-digesubstitueer- de piperidinen alsmede farmaceutische preparaten die deze verbindingen als actieve componenten omvatten.
NL170284C (nl) Werkwijze ter bereiding van 1.2.3.5.6.12.13.13a-octahydro 12 oxoindolo Ÿ3.2.1-d.eŸpyrido Ÿ3.2.1-i.jŸnaftyridinen, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL148317B (nl) Werkwijze voor de bereiding van benzo (b) thiofeenazijnzuurderivaten, en van preparaten die ze bevatten.
NL172657C (nl) Werkwijze ter bereiding van een farmaceutisch preparaat en werkwijze ter bereiding van daarbij bruikbare pyrazoloÿ3.4-bÿ-pyridine-derivaten.
NL149812B (nl) Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat.
NL173167C (nl) Werkwijze ter bereiding van farmaceutische preparaten, op basis van n-acyltryptofaanderivaten, alsmede werkwijze ter bereiding van n-acyltryptofaanderivaten.
NL172446C (nl) Werkwijze voor de bereiding van 4-aryl-1-(4.4-diarylbutyl)4-hydroxypiperidinen en werkwijze voor de bereiding van farmaceutische preparaten.
NL164037C (nl) Werkwijze ter bereiding van 1,4-dithiino- -Ÿ2,3-cŸpyrrool-derivaten en van farmaceutische preparaten die deze derivaten bevatten.
NL149082B (nl) Werkwijze ter bereiding van farmaceutische preparaten, gevormde preparaten en werkwijze ter bereiding van daarvoor geschikte thiazolino (3,2-a)-5-pyrimidinonderivaten.
NL7409840A (nl) Werkwijze ter bereiding van thienopyridinecar- bonzuurderivaten, alsmede werkwijze ter berei- ding van farmaceutische preparaten die deze derivaten bevatten.
NL168497B (nl) Werkwijze voor de bereiding van 2-(o-anilino-fenyl) ethaanderivaten, werkwijze ter bereiding van farma- ceutische preparaten, die deze verbindingen bevatten en verkregen farmaceutische preparaten.
NL7411347A (nl) 4-hydroxychinolineverbindingen en geneesmidde- len die deze verbindingen bevatten.
NL171582C (nl) Werkwijze ter bereiding van een 2,4-diamino-5-benzylpyrimidine, alsmede van farmaceutische preparaten, die een dergelijke verbinding bevatten.
NL153878B (nl) Werkwijze ter bereiding van 1,17-digesubstitueerde oestradiolderivaten, alsmede werkwijze ter bereiding van een farmaceutisch preparaat.

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee